Conoidin A is primarily studied for its potential applications in biological and medical research. It has shown significant promise as an inhibitor of peroxiredoxin proteins, which play a role in cellular redox signaling and antioxidant defense. By targeting these proteins, Conoidin A can be used to study oxidative stress mechanisms and their impact on cellular functions. This makes it a valuable tool in understanding diseases related to oxidative damage, such as cancer, neurodegenerative disorders, and inflammatory conditions. Additionally, its ability to modulate redox pathways offers insights into developing therapeutic strategies aimed at controlling oxidative stress in various pathological conditions.